These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 26927385)
21. A preliminary study of plasma cyclase-associated protein 2 as a novel biomarker for early stage and alpha-fetoprotein negative hepatocellular carcinoma patients. Chen M; Zheng T; Han S; Zhang L; Bai Y; Fang X; Ding SZ; Yang Y Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):215-21. PubMed ID: 25312778 [TBL] [Abstract][Full Text] [Related]
22. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma. Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578 [TBL] [Abstract][Full Text] [Related]
23. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells]. Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080 [TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma. Thimme R; Neagu M; Boettler T; Neumann-Haefelin C; Kersting N; Geissler M; Makowiec F; Obermaier R; Hopt UT; Blum HE; Spangenberg HC Hepatology; 2008 Dec; 48(6):1821-33. PubMed ID: 19003875 [TBL] [Abstract][Full Text] [Related]
26. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration]. Xie YM; Yan LN; Wei B; Guo MM; Tang CW Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741 [TBL] [Abstract][Full Text] [Related]
27. Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma. Görög D; Regöly-Mérei J; Paku S; Kopper L; Nagy P World J Gastroenterol; 2005 Aug; 11(32):5015-8. PubMed ID: 16124056 [TBL] [Abstract][Full Text] [Related]
28. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma. Chao X; Zhang W; Wu J; Feng X; Shi H; Zhao L; Shen H; Jiang C Biomed Res Int; 2021; 2021():1971048. PubMed ID: 34485511 [TBL] [Abstract][Full Text] [Related]
29. Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems. Zhang XF; Qi X; Meng B; Liu C; Yu L; Wang B; Lv Y Eur J Surg Oncol; 2010 Aug; 36(8):718-24. PubMed ID: 20538423 [TBL] [Abstract][Full Text] [Related]
30. Distinctions between clinicopathological factors and prognosis of alpha-fetoprotein negative and positive hepatocelluar carcinoma patients. Xu J; Liu C; Zhou L; Tian F; Tai MH; Wei JC; Qu K; Meng FD; Zhang LQ; Wang ZX; Zhang JY; Chang HL; Liu SN; Xu XS; Song YZ; Liu J; Zhang P Asian Pac J Cancer Prev; 2012; 13(2):559-62. PubMed ID: 22524824 [TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization. Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305 [TBL] [Abstract][Full Text] [Related]
32. [Expression and clinical significance of soluble B7-H3 in sera of patients with primary hepatocellular carcinoma]. Wang F; Yu G; Liu T; Wang G; Yang J; Zhang G; Luan X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):629-32. PubMed ID: 23746248 [TBL] [Abstract][Full Text] [Related]
33. Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma. Ng KT; Man K; Sun CK; Lee TK; Poon RT; Lo CM; Fan ST Br J Cancer; 2006 Oct; 95(8):1050-5. PubMed ID: 17008870 [TBL] [Abstract][Full Text] [Related]
34. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy. Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841 [TBL] [Abstract][Full Text] [Related]
35. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis. Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512 [TBL] [Abstract][Full Text] [Related]
36. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663 [TBL] [Abstract][Full Text] [Related]
37. Prognostic implications of ezrin expression in human hepatocellular carcinoma. Kang YK; Hong SW; Lee H; Kim WH Mol Carcinog; 2010 Sep; 49(9):798-804. PubMed ID: 20572160 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers. Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein. Zhou L; He J; Zhang Y J Int Med Res; 2013 Aug; 41(4):1009-16. PubMed ID: 23766411 [TBL] [Abstract][Full Text] [Related]
40. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]